HSDT
Solana Co
NASDAQ · Healthcare · Medical - Devices · US
$2.10
+1.94%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$2.06
From 52W high−61.82%
Volume1.28M
Market cap$136.72M
P/E (TTM)—
P/S (TTM)11.3x
Div yield—
Key dataNov 4, 2026
Open
$2.06
From 52W high
−61.82%
Volume
1.28M
Market cap
$136.72M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−1.0x
P/E (TTM)
—
RSI (14)
39.5
MomentumView details →
1D Return
+1.94%
YTD Return
−27.68%
SummaryUpdated Jun 1, 2026
Helius Medical Technologies, Inc. (NASDAQ:HSDT) is a neurotechnology company founded in 2014 and headquartered in Newtown, Pennsylvania. The company specializes in developing non-invasive medical devices for treating neurological conditions, with its flagship product being the Portable Neuromodulation Stimulator (PoNS). Since going public in 2014, Helius has focused on commercializing its neurostimulation technology for patients suffering from balance and gait deficits caused by multiple sclerosis, traumatic brain injury, and stroke.
Similar companies
Latest newsMore news →
An unidentified Solana Co holder transferred 1.49 million SOL, worth approximately USD 148.77 million, to several exchanges over ten days, according to Lookonchain.1d agoPolygon.io, Inc. expanded its OMS to let eligible foreign businesses connect Solana Co stablecoins to U.S. banking rails after verification, subject to early-access and jurisdiction limits.2d ago